These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 7854521)

  • 21. Reliability of gait in multiple sclerosis over 6 months.
    Sosnoff JJ; Klaren RE; Pilutti LA; Dlugonski D; Motl RW
    Gait Posture; 2015 Mar; 41(3):860-2. PubMed ID: 25772669
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Changes in disability in people with multiple sclerosis: a 10-year prospective study.
    Conradsson D; Ytterberg C; von Koch L; Johansson S
    J Neurol; 2018 Jan; 265(1):119-126. PubMed ID: 29159465
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mitoxantrone: a review of its use in multiple sclerosis.
    Scott LJ; Figgitt DP
    CNS Drugs; 2004; 18(6):379-96. PubMed ID: 15089110
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Spatial and temporal characteristics of gait as outcome measures in multiple sclerosis (EDSS 0 to 6.5).
    Lizrova Preiningerova J; Novotna K; Rusz J; Sucha L; Ruzicka E; Havrdova E
    J Neuroeng Rehabil; 2015 Feb; 12():14. PubMed ID: 25890382
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Assessing incapacity at early stages of Multiple sclerosis using the EDSS].
    Brochet B
    Rev Neurol (Paris); 2009 Mar; 165 Suppl 4():S173-9. PubMed ID: 19361684
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Disability weight for each level of the Expanded Disability Status Scale in multiple sclerosis.
    Cho JY; Hong KS; Kim HJ; Kim SH; Min JH; Kim NH; Ahn SW; Park MS; An JY; Kim BJ; Kim W
    Mult Scler; 2014 Aug; 20(9):1217-23. PubMed ID: 24399825
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multiple sclerosis: assessment of disability and disability scales.
    Thompson AJ; Hobart JC
    J Neurol; 1998 Apr; 245(4):189-96. PubMed ID: 9591219
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neurostatus e-Scoring improves consistency of Expanded Disability Status Scale assessments: A proof of concept study.
    D'Souza M; Yaldizli Ö; John R; Vogt DR; Papadopoulou A; Lucassen E; Menegola M; Andelova M; Dahlke F; Schnyder F; Kappos L
    Mult Scler; 2017 Apr; 23(4):597-603. PubMed ID: 27364325
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Patient reported outcomes in benign multiple sclerosis.
    Hviid LE; Healy BC; Rintell DJ; Chitnis T; Weiner HL; Glanz BI
    Mult Scler; 2011 Jul; 17(7):876-84. PubMed ID: 21372114
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The natural history of primary progressive MS in British Columbia, Canada.
    Tremlett H; Paty D; Devonshire V
    Neurology; 2005 Dec; 65(12):1919-23. PubMed ID: 16380613
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Importance of an individual's evaluation of functional status for health-related quality of life in patients with multiple sclerosis.
    Gavelova M; Nagyova I; Rosenberger J; Krokavcova M; Gdovinova Z; Groothoff JW; van Dijk JP
    Disabil Health J; 2015 Jul; 8(3):372-9. PubMed ID: 25981341
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Erratum.
    Mult Scler; 2016 Oct; 22(12):NP9-NP11. PubMed ID: 26041800
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quantification of Gait Abnormalities in Healthy-Looking Multiple Sclerosis Patients (with Expanded Disability Status Scale 0-1.5).
    Novotna K; Sobisek L; Horakova D; Havrdova E; Lizrova Preiningerova J
    Eur Neurol; 2016; 76(3-4):99-104. PubMed ID: 27497974
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Change in MS-related disability in a population-based cohort: a 10-year follow-up study.
    Pittock SJ; Mayr WT; McClelland RL; Jorgensen NW; Weigand SD; Noseworthy JH; Weinshenker BG; Rodriguez M
    Neurology; 2004 Jan; 62(1):51-9. PubMed ID: 14718697
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Free-living and laboratory gait characteristics in patients with multiple sclerosis.
    Storm FA; Nair KPS; Clarke AJ; Van der Meulen JM; Mazzà C
    PLoS One; 2018; 13(5):e0196463. PubMed ID: 29715279
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Documenting outdoor activity and travel behaviour in persons with neurological conditions using travel diaries and GPS tracking technology: a pilot study in multiple sclerosis.
    Neven A; Janssens D; Alders G; Wets G; Van Wijmeersch B; Feys P
    Disabil Rehabil; 2013 Sep; 35(20):1718-25. PubMed ID: 23343357
    [TBL] [Abstract][Full Text] [Related]  

  • 37. European validation of a standardized clinical description of multiple sclerosis.
    Amato MP; Grimaud J; Achiti I; Bartolozzi ML; Adeleine P; Hartung HP; Kappos L; Thompson A; Trojano M; Vukusic S; Confavreux C;
    J Neurol; 2004 Dec; 251(12):1472-80. PubMed ID: 15645346
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tried and tested: the psychometric properties of the multiple sclerosis impact scale (MSIS-29) in a population-based study.
    Gray O; McDonnell G; Hawkins S
    Mult Scler; 2009 Jan; 15(1):75-80. PubMed ID: 18829636
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Walking function in clinical monitoring of multiple sclerosis by telemedicine.
    Sola-Valls N; Blanco Y; Sepúlveda M; Llufriu S; Martínez-Lapiscina EH; La Puma D; Graus F; Villoslada P; Saiz A
    J Neurol; 2015 Jul; 262(7):1706-13. PubMed ID: 25957639
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Observer disagreement in rating neurologic impairment in multiple sclerosis: facts and consequences.
    Verdier-Taillefer MH; Zuber M; Lyon-Caen O; Clanet M; Gout O; Louis C; Alpérovitch A
    Eur Neurol; 1991; 31(2):117-9. PubMed ID: 2044616
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.